Hybrid Ablation: A Role in AF Management?
Overview
Join a panel of International faculty as they discuss the clinical value of hybrid ablation treatment strategies for persistent atrial fibrillation (AF).
Can it improve patient outcomes? What evidence base is available to support this? How can it be implemented effectively in clinical practice?
Available from 06/07/2018 until 06/07/2023.
Target Audience
This programme is intended to educate:
- Interventional Cardiologists
- Cardiologists
Learning Objectives
At the end of this programme, delegates will be able to:
• Define the clinical value of a multidisciplinary “AF Heart Team”.
• Analyse the scientific evidence that supports the safety and efficacy of hybrid ablation techniques.
• Propose how to effectively implement a hybrid approach to managing AF in their clinical practice.
Disclosures
This programme is accredited by the European Board for Accreditation in Cardiology (EBAC) for 1 hour of external CME credit(s). Each participant should claim only those hours of credit that have actually been spent in the educational activity. EBAC works according to the quality standards of the European Accreditation Council for Continuing Medical Education (EACCME), which is an institution of the European Union of Medical Specialists (UEMS). In compliance with EBAC/ EACCME guidelines, all speakers/chairpersons participating in this programme have disclosed or indicated potential conflicts of interest which might cause a bias in the presentations. The Organizing Committee/Course Director is responsible for ensuring that all potential conflicts of interest relevant to the event are declared to the audience prior to the CME activities.
This activity has been supported by an unrestricted educational grant from AtriCure Inc.
R-CME Disclaimer / Terms & Conditions
Instructions to Participants
There is no fee for taking part in this online learning activity.
Activities are designed to be completed within 60 minutes and must be completed by the registered user. Physicians should only claim credits for time spent on the activity. To successfully earn credit, participants must complete the activity in full in the indicated time frame.
To complete the course and claim certification participants must:
1. Read the course outline information supplied and complete pre-test questions if supplied prior to starting the activity. Users must read and study the activity in its entirety before completing the post-test questions.
2. Your results will be automatically saved and if a pass score is achieved (where applicable), you may be eligible to claim credit for the activity and receive a certificate of completion.
Chair:
Professor Harry Crijns
Chair of Cardiology, Maastricht University Medical Centre, Netherlands
Speaker:
Professor Lucas Boersma
Head of Cardiology and Chairman of the Netherlands Heart Rhythm Association, St. Antonius Ziekenhuis, Nieuwegein, Netherlands
Speaker:
Professor Claudio Tondo
Director of Cardiac Arrhythmia Research Center at Centro Cardiologico Monzino, University of Milan, Italy
Speaker:
Dr Nitesh Sood
MD Clinical Cardiac Electrophysiology, Charlton Memorial Hospital Fall River, Massachusetts, USA
Please note that relevant faculty disclosures are included in the presentations.
This activity has been supported by an unrestricted educational grant from AtriCure Inc.
The event “Hybrid ablation: a role in AF management?” is accredited by the European Board for Accreditation in Cardiology (EBAC) for 1 hour of external CME credits.
Each participant should claim only those hours of credit that have actually been spent in the educational activity. EBAC works according to the quality standards of the European Accreditation Council for Continuing Medical Education (EACCME), which is an institution of the European Union of Medical Specialists (UEMS).
Available Credit
- 1.00 European Board for Accreditation in Cardiology (EBAC)